메뉴 건너뛰기




Volumn 21, Issue 5, 1999, Pages 227-232

Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ turnouts

Author keywords

Cancel Clearance; Clinical pharmacokinetics; Distribution; Gentamicin; Monitoring

Indexed keywords

GENTAMICIN;

EID: 0032823701     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008708119954     Document Type: Article
Times cited : (4)

References (37)
  • 1
    • 0345224581 scopus 로고
    • Chapter 46: Immunocompromised host infections
    • Kode-Kimble MA, Young LY, eds. Applied Therapeutics Applied Therapeutics Inc
    • Mandler HD, Dudley MN. Chapter 46: Immunocompromised host infections. In: Kode-Kimble MA, Young LY, eds. Applied Therapeutics. The clinical use of drugs. Fifth Ed. Applied Therapeutics Inc; 1992.
    • (1992) The Clinical use of Drugs. Fifth Ed.
    • Mandler, H.D.1    Dudley, M.N.2
  • 2
    • 0344361822 scopus 로고
    • Chapter 14: Aminoglycosides
    • Evans WE, Schentag EE and Jusko J, eds. Applied Pharmacokinetics. Vancouver: Applied Therapeutics, Inc
    • Zaske DE. Chapter 14: Aminoglycosides. In: Evans WE, Schentag EE and Jusko J, eds. Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring. Vancouver: Applied Therapeutics, Inc; 1992.
    • (1992) Principles of Therapeutic Drug Monitoring
    • Zaske, D.E.1
  • 4
    • 0023119430 scopus 로고
    • Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration
    • Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-9.
    • (1987) J Infect Dis , vol.155 , pp. 93-99
    • Moore, R.D.1    Lietman, P.S.2    Smith, C.R.3
  • 7
    • 0018979475 scopus 로고
    • Gentamicin dosage requirements: Wide interpatient variation in 242 surgery patients with normal renal function
    • Zaske DE, Cipolle RJ, Strate RJ. Gentamicin dosage requirements: wide interpatient variation in 242 surgery patients with normal renal function. Surgery 1980;87:164-9.
    • (1980) Surgery , vol.87 , pp. 164-169
    • Zaske, D.E.1    Cipolle, R.J.2    Strate, R.J.3
  • 8
    • 0028341368 scopus 로고
    • Selection of optimal prophylactic amonoglycoside dosage in cancer patients: Population pharmacokinetic approaches
    • Ordovas JP, Ronchera CL, Poveda N, Jimenez NV, Lopez R. Selection of optimal prophylactic amonoglycoside dosage in cancer patients: population pharmacokinetic approaches. J Clin Pharm Ther 1994;19:47-56.
    • (1994) J Clin Pharm Ther , vol.19 , pp. 47-56
    • Ordovas, J.P.1    Ronchera, C.L.2    Poveda, N.3    Jimenez, N.V.4    Lopez, R.5
  • 9
    • 0027217273 scopus 로고
    • Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy
    • Inciardi JF, Batra KK. Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy. Antimicrob Agts Chemother 1993;37:1025-7.
    • (1993) Antimicrob Agts Chemother , vol.37 , pp. 1025-1027
    • Inciardi, J.F.1    Batra, K.K.2
  • 10
  • 12
    • 0017204845 scopus 로고
    • Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients
    • Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharmacokinet Biopharm 1976;4:183-95.
    • (1976) J Pharmacokinet Biopharm , vol.4 , pp. 183-195
    • Sawchuk, R.J.1    Zaske, D.E.2
  • 13
    • 0031976778 scopus 로고    scopus 로고
    • Population pharmacokinetic parameters of gentamicin in solid tumour patients. Estimation by one and two stage methods
    • Ortega A, Aldaz A, Giráldez J, Brugarolas A. Population pharmacokinetic parameters of gentamicin in solid tumour patients. Estimation by one and two stage methods. Ther Drug Monit 1998;20:184-90.
    • (1998) Ther Drug Monit , vol.20 , pp. 184-190
    • Ortega, A.1    Aldaz, A.2    Giráldez, J.3    Brugarolas, A.4
  • 16
    • 0028281786 scopus 로고
    • Lean Body Mass as a predictor of drug dosage. Implications for drug therapy
    • Morgan DJ, Bray KM. Lean Body Mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 1994;26:92-307.
    • (1994) Clin Pharmacokinet , vol.26 , pp. 92-307
    • Morgan, D.J.1    Bray, K.M.2
  • 18
    • 0023852057 scopus 로고
    • Validation of the use of bayesian analysis in the optimization of gentamicin therapy from the commencement of dosing
    • Chrystyn H. Validation of the use of bayesian analysis in the optimization of gentamicin therapy from the commencement of dosing. Drug Intell Clin Pharm 1988;22:49-53.
    • (1988) Drug Intell Clin Pharm , vol.22 , pp. 49-53
    • Chrystyn, H.1
  • 19
    • 0023155096 scopus 로고
    • Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis
    • Mann MJ, Fuhs DW, Awang R, Ndemo FA, Cerra FB. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharm 1987;6:148-53.
    • (1987) Clin Pharm , vol.6 , pp. 148-153
    • Mann, M.J.1    Fuhs, D.W.2    Awang, R.3    Ndemo, F.A.4    Cerra, F.B.5
  • 20
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Crockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-4.
    • (1976) Nephron , vol.16 , pp. 31-34
    • Crockcroft, D.W.1    Gault, M.H.2
  • 21
    • 0002953816 scopus 로고
    • A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex and weight
    • Jelliffe RW, Jelliffe SM. A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex and weight. Math Biosci 1972;14:17-24.
    • (1972) Math Biosci , vol.14 , pp. 17-24
    • Jelliffe, R.W.1    Jelliffe, S.M.2
  • 22
  • 24
    • 0025978835 scopus 로고
    • Is there a reliable index of glomerular filtration rate in critically ill patients?
    • Robert S, Zarowitz BJ. Is there a reliable index of glomerular filtration rate in critically ill patients? DICP Ann Pharmacother 1991;25:169-78.
    • (1991) DICP Ann Pharmacother , vol.25 , pp. 169-178
    • Robert, S.1    Zarowitz, B.J.2
  • 25
    • 0019487328 scopus 로고
    • Influence of range of renal function and liver disease on predictability of creatinine clearance
    • Hull JH, Hark LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM. Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther 1981;29(4):516-21.
    • (1981) Clin Pharmacol Ther , vol.29 , Issue.4 , pp. 516-521
    • Hull, J.H.1    Hark, L.J.2    Koch, G.G.3    Wargin, W.A.4    Chi, S.L.5    Mattocks, A.M.6
  • 26
    • 0000793889 scopus 로고
    • Estimation of creatinine clearance from serum creatinine concentration-a review
    • Lott RS, Hayton WL. Estimation of creatinine clearance from serum creatinine concentration-a review. Drug Intell Clin Pharm 1978;12:140-50.
    • (1978) Drug Intell Clin Pharm , vol.12 , pp. 140-150
    • Lott, R.S.1    Hayton, W.L.2
  • 27
    • 0344361820 scopus 로고
    • Estimation of creatinine clearance in malnourished patients
    • Lau AH, Bek SI, Posser T, Stonich T. Estimation of creatinine clearance in malnourished patients. Clin Pharm 1991;10:706-10.
    • (1991) Clin Pharm , vol.10 , pp. 706-710
    • Lau, A.H.1    Bek, S.I.2    Posser, T.3    Stonich, T.4
  • 28
    • 0020533651 scopus 로고
    • Decreased rate of creatinine production in patients with hepatic disease: Implications for estimation of creatinine clearance
    • Cochetto DM, Tschanz Ch, Bjornsson TD. Decreased rate of creatinine production in patients with hepatic disease: Implications for estimation of creatinine clearance. Ther Drug Monit 1983;5:161-68.
    • (1983) Ther Drug Monit , vol.5 , pp. 161-168
    • Cochetto, D.M.1    Tschanz, Ch.2    Bjornsson, T.D.3
  • 29
    • 0023771720 scopus 로고
    • Superiority of disease-specific over conventional formula in predicing creatinine clearance from serum creatinine in patients with liver cirrhosis
    • Echizen H, Ishizaki T. Superiority of disease-specific over conventional formula in predicing creatinine clearance from serum creatinine in patients with liver cirrhosis. Ther Drug Monit 1988;10:369-75.
    • (1988) Ther Drug Monit , vol.10 , pp. 369-375
    • Echizen, H.1    Ishizaki, T.2
  • 30
    • 0018472223 scopus 로고
    • Use of serum creatinine concentrations to determine renal function
    • Bjornsson TD. Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet 1979;4:200-22.
    • (1979) Clin Pharmacokinet , vol.4 , pp. 200-222
    • Bjornsson, T.D.1
  • 31
    • 0026713374 scopus 로고
    • Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients
    • Zarowitz BJ, Robert S, Peterson EL. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Ann Pharmacother 1992;26:1205-10.
    • (1992) Ann Pharmacother , vol.26 , pp. 1205-1210
    • Zarowitz, B.J.1    Robert, S.2    Peterson, E.L.3
  • 32
    • 0027422833 scopus 로고
    • Predicting vancomycin pharmacokinetics by using aminoglycosides pharmacokinetics
    • Welch LP, Leader WG, Chandler MHH. Predicting vancomycin pharmacokinetics by using aminoglycosides pharmacokinetics. Clin Pharm 1993;12:909-13.
    • (1993) Clin Pharm , vol.12 , pp. 909-913
    • Welch, L.P.1    Leader, W.G.2    Chandler, M.H.H.3
  • 33
    • 0027291455 scopus 로고
    • Estimation of creatinine clearance in patients with gynecologic cancer
    • Tsubaki T, Goodin S, Leader WG, Chandler MHH. Estimation of creatinine clearance in patients with gynecologic cancer. Clin Pharm 1993;12:685-90.
    • (1993) Clin Pharm , vol.12 , pp. 685-690
    • Tsubaki, T.1    Goodin, S.2    Leader, W.G.3    Chandler, M.H.H.4
  • 34
    • 0344361818 scopus 로고    scopus 로고
    • Laboratory of Applied Pharmacokinetics. University of Southern California. School of Medicine. Los Angeles. California
    • Jelliffe RW, Schumitzky A, Van Guilder M. USC*PACK collection of PC programs. Laboratory of Applied Pharmacokinetics. University of Southern California. School of Medicine. Los Angeles. California.
    • USC*PACK Collection of PC Programs
    • Jelliffe, R.W.1    Schumitzky, A.2    Van Guilder, M.3
  • 35
    • 0344361817 scopus 로고
    • Farmacocinética aplicada: Aminoglicósidos
    • Miranda, Maldonado. Farmacocinética aplicada: aminoglicósidos. Revista de la O.F.I.L 1993;3:397-407.
    • (1993) Revista de la O.F.I.L , vol.3 , pp. 397-407
    • Miranda, M.1
  • 36
    • 0020522160 scopus 로고
    • Gentamicin and Tobramycin dosing guidelines. An evaluation
    • Matzke GR, Burkle WS, Lucarotti. Gentamicin and Tobramycin dosing guidelines. An evaluation. Drug Intell Clin Pharm 1983;17:425-32.
    • (1983) Drug Intell Clin Pharm , vol.17 , pp. 425-432
    • Matzke, G.R.1    Burkle, W.S.2    Lucarotti3
  • 37
    • 0023757326 scopus 로고
    • Gentamicin volumes of distribution in patients with hematologic disorders
    • Philips JK, Spearing RL, Crome DJ, Davies JM. Gentamicin volumes of distribution in patients with hematologic disorders. N Engl J Med 1988;10:1290.
    • (1988) N Engl J Med , vol.10 , pp. 1290
    • Philips, J.K.1    Spearing, R.L.2    Crome, D.J.3    Davies, J.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.